These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36531952)

  • 1. The potential therapeutic value and application prospect of engineered exosomes in human diseases.
    Liu G; Wu J; Chen G; Shang A
    Front Cell Dev Biol; 2022; 10():1051380. PubMed ID: 36531952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-derived Exosomes: Pioneering Breakthroughs in Therapeutics, Targeted Drug Delivery, and Regenerative Medicine.
    Dutta S; Ghosh S; Rahaman M; Chowdhury SR
    Pharm Nanotechnol; 2024 Jun; ():. PubMed ID: 38840389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research progress of exosomes in pathogenesis, diagnosis, and treatment of ocular diseases.
    Feng X; Peng Z; Yuan L; Jin M; Hu H; Peng X; Wang Y; Zhang C; Luo Z; Liao H
    Front Bioeng Biotechnol; 2023; 11():1100310. PubMed ID: 36761297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removing the stumbling block of exosome applications in clinical and translational medicine: expand production and improve accuracy.
    Han L; Zhao Z; He C; Li J; Li X; Lu M
    Stem Cell Res Ther; 2023 Apr; 14(1):57. PubMed ID: 37005658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles.
    Rao D; Huang D; Sang C; Zhong T; Zhang Z; Tang Z
    Front Bioeng Biotechnol; 2021; 9():797359. PubMed ID: 35186913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative Diagnosis and Therapeutic Modalities: Engineered Exosomes in Autoimmune Disease.
    Ji Y; Mi L; Zhao M; He X; Hu Y; Gao Y; Yin C; Xu K
    Int J Nanomedicine; 2024; 19():3943-3956. PubMed ID: 38708179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered exosomes: A new promise for the management of musculoskeletal diseases.
    Bellavia D; Raimondi L; Costa V; De Luca A; Carina V; Maglio M; Fini M; Alessandro R; Giavaresi G
    Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1893-1901. PubMed ID: 29885361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progenitor cell-derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects.
    Zha Y; Li Y; Lin T; Chen J; Zhang S; Wang J
    Theranostics; 2021; 11(1):397-409. PubMed ID: 33391482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles for Immunomodulation in Tissue Regeneration.
    Zhang K; Liu L; Shi K; Zhang K; Zheng C; Jin Y
    Tissue Eng Part C Methods; 2022 Aug; 28(8):393-404. PubMed ID: 35856810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Progress in the Application of Exosomes in Immunotherapy.
    Zhang X; Xu D; Song Y; He R; Wang T
    Front Immunol; 2022; 13():731516. PubMed ID: 35242126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes in Dogs and Cats: An Innovative Approach to Neoplastic and Non-Neoplastic Diseases.
    Diomaiuto E; Principe V; De Luca A; Laperuta F; Alterisio C; Di Loria A
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model" [International Journal of Pharmaceutics 549 (2018) 218-229].
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2019 Mar; 558():441. PubMed ID: 30765106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes.
    Choi H; Choi Y; Yim HY; Mirzaaghasi A; Yoo JK; Choi C
    Tissue Eng Regen Med; 2021 Aug; 18(4):499-511. PubMed ID: 34260047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle.
    Lässer C
    Expert Opin Biol Ther; 2015 Jan; 15(1):103-17. PubMed ID: 25363342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases.
    Jiang Y; Wang F; Wang K; Zhong Y; Wei X; Wang Q; Zhang H
    Curr Med Chem; 2022; 29(17):3111-3124. PubMed ID: 34477508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.
    Liu R; Liu J; Ji X; Liu Y
    Metab Brain Dis; 2013 Dec; 28(4):551-62. PubMed ID: 24022398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.